LCE5A
gene geneOn this page
Also known as LEP18
Summary
LCE5A (late cornified envelope 5A, HGNC:16614) is a protein-coding gene on chromosome 1q21.3, encoding Late cornified envelope protein 5A (Q5TCM9). Precursors of the cornified envelope of the stratum corneum.
Enables identical protein binding activity. Predicted to be involved in keratinization.
Source: NCBI Gene 254910 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 16 total
- MANE Select transcript:
NM_178438
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16614 |
| Approved symbol | LCE5A |
| Name | late cornified envelope 5A |
| Location | 1q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LEP18 |
| Ensembl gene | ENSG00000186207 |
| Ensembl biotype | protein_coding |
| OMIM | 612619 |
| Entrez | 254910 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334269
RefSeq mRNA: 1 — MANE Select: NM_178438
NM_178438
CCDS: CCDS1011
Canonical transcript exons
ENST00000334269 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001338723 | 152511514 | 152512177 |
| ENSE00001447966 | 152510803 | 152510998 |
Expression profiles
Bgee: expression breadth broad, 81 present calls, max score 91.57.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2587 / max 366.4013, expressed in 5 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 5301 | 0.2587 | 5 |
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 91.57 | gold quality |
| zone of skin | UBERON:0000014 | 89.24 | gold quality |
| skin of abdomen | UBERON:0001416 | 85.97 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 59.96 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 56.83 | gold quality |
| cortical plate | UBERON:0005343 | 45.46 | gold quality |
| bone marrow cell | CL:0002092 | 43.86 | gold quality |
| esophagus mucosa | UBERON:0002469 | 41.86 | gold quality |
| bone marrow | UBERON:0002371 | 40.88 | gold quality |
| ventricular zone | UBERON:0003053 | 40.75 | silver quality |
| vagina | UBERON:0000996 | 39.00 | gold quality |
| right lung | UBERON:0002167 | 38.90 | silver quality |
| left testis | UBERON:0004533 | 38.30 | gold quality |
| granulocyte | CL:0000094 | 38.28 | gold quality |
| blood | UBERON:0000178 | 37.90 | gold quality |
| testis | UBERON:0000473 | 37.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.59 | silver quality |
| putamen | UBERON:0001874 | 37.55 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.83 | gold quality |
| multicellular organism | UBERON:0000468 | 36.80 | gold quality |
| right testis | UBERON:0004534 | 36.67 | gold quality |
| gastrocnemius | UBERON:0001388 | 36.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 36.36 | gold quality |
| esophagus | UBERON:0001043 | 36.23 | gold quality |
| sural nerve | UBERON:0015488 | 36.22 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 35.82 | gold quality |
| muscle of leg | UBERON:0001383 | 35.58 | gold quality |
| amygdala | UBERON:0001876 | 35.56 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting LCE5A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-9902 | 99.89 | 69.15 | 2250 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-3919 | 99.87 | 69.45 | 2489 |
| HSA-MIR-5093 | 99.67 | 69.26 | 2291 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-4755-3P | 98.77 | 65.59 | 1915 |
| HSA-MIR-4712-3P | 98.52 | 65.39 | 822 |
| HSA-MIR-654-3P | 98.38 | 67.61 | 905 |
| HSA-MIR-122-5P | 97.23 | 64.92 | 1024 |
| HSA-MIR-4268 | 94.45 | 64.09 | 819 |
Literature-anchored findings (GeneRIF, showing 1)
- paper describing nomenclature changes and expression in range of tissues and in response to UV (PMID:15854049)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lce1g | ENSMUSG00000027919 |
| mus_musculus | Lce1e | ENSMUSG00000068889 |
| rattus_norvegicus | Lce1g | ENSRNOG00000070872 |
Paralogs (20): LCE2B (ENSG00000159455), SPRR2G (ENSG00000159516), LCE3D (ENSG00000163202), SPRR3 (ENSG00000163209), SPRR1B (ENSG00000169469), SPRR1A (ENSG00000169474), LCE1D (ENSG00000172155), SPRR4 (ENSG00000184148), LCE3A (ENSG00000185962), LCE3E (ENSG00000185966), LCE1E (ENSG00000186226), LCE2A (ENSG00000187173), LCE2C (ENSG00000187180), LCE2D (ENSG00000187223), LCE3B (ENSG00000187238), KPLCE (ENSG00000198854), PRR9 (ENSG00000203783), LELP1 (ENSG00000203784), LCE1F (ENSG00000240386), LCE3C (ENSG00000244057)
Protein
Protein identifiers
Late cornified envelope protein 5A — Q5TCM9 (reviewed: Q5TCM9)
Alternative names: Late envelope protein 18, Small proline-rich-like epidermal differentiation complex protein 5A
All UniProt accessions (1): Q5TCM9
UniProt curated annotations — full annotation on UniProt →
Function. Precursors of the cornified envelope of the stratum corneum.
Subunit / interactions. Interacts with CYSRT1; the interaction is direct.
Tissue specificity. Skin-specific. Expression was readily detected in adult trunk skin, adult arm skin, fetal skin, penal skin, vulva, esophagus and tongue. Not expressed in the cervix, rectum, lung, colon, or placenta. Expression is observed in the heart.
Miscellaneous. Belongs to the LCE cluster present on 1q21.
Similarity. Belongs to the LCE family.
RefSeq proteins (1): NP_848525* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028205 | LCE | Family |
Pfam: PF14672
UniProt features (8 total): compositionally biased region 4, region of interest 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TCM9-F1 | 53.12 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-6809371 | Formation of the cornified envelope |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 19 (showing top):
GOBP_EPITHELIUM_DEVELOPMENT, GCANCTGNY_MYOD_Q6, GOBP_EPIDERMAL_CELL_DIFFERENTIATION, GOBP_EPIDERMIS_DEVELOPMENT, TATA_C, GOBP_KERATINIZATION, GOBP_SKIN_DEVELOPMENT, chr1q21, MARTENS_TRETINOIN_RESPONSE_UP, REACTOME_KERATINIZATION, REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE, GOBP_KERATINOCYTE_DIFFERENTIATION, GOBP_EPITHELIAL_CELL_DIFFERENTIATION, MIR6721_5P, TATA_01
GO Biological Process (2): keratinization (GO:0031424), epidermis development (GO:0008544)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (0):
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Keratinization | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| keratinocyte differentiation | 1 |
| multicellular organismal process | 1 |
| tissue development | 1 |
| protein binding | 1 |
| binding | 1 |
Protein interactions and networks
STRING
314 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LCE5A | LCE4A | Q5TA78 | 970 |
| LCE5A | LCE1A | Q5T7P2 | 910 |
| LCE5A | LCE1D | Q5T752 | 620 |
| LCE5A | LCE6A | A0A183 | 601 |
| LCE5A | LCE2B | O14633 | 582 |
| LCE5A | LCE1C | Q5T751 | 575 |
| LCE5A | LCE3C | Q5T5A8 | 550 |
| LCE5A | LCE2C | Q5TA81 | 542 |
| LCE5A | LCE2D | Q5TA82 | 540 |
| LCE5A | SPRR1B | P22528 | 535 |
| LCE5A | LCE2A | Q5TA79 | 528 |
| LCE5A | RPTN | Q6XPR3 | 518 |
| LCE5A | LCE3E | Q5T5B0 | 505 |
| LCE5A | LCE1F | Q5T754 | 505 |
| LCE5A | KCTD6 | Q8NC69 | 475 |
IntAct
250 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LCE5A | KRTAP4-12 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE5A | LCE5A | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE5A | KRTAP5-3 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE5A | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP10-9 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE5A | UBE2I | psi-mi:“MI:0915”(physical association) | 0.560 |
| NUTF2 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| RGS20 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-9 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLC | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | KRTAP9-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | PLSCR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-3 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP6-3 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-1 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| HOXA1 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | PLSCR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2C | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-3 | LCE5A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | KRTAP4-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | RGS17 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | NECTIN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | CHIC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE5A | KRTAP5-11 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (90): LCE5A (Synthetic Lethality), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid), LCE5A (Two-hybrid)
ESM2 similar proteins: A0A1B0GTR4, A6QNZ4, O14633, O70554, O70555, O70556, O70557, O70558, O70559, O70560, O70562, P15265, P22528, P22531, P22532, P35321, P35322, P35323, P35324, P35325, P35326, P49901, Q28658, Q32L04, Q4KL71, Q4R956, Q5T5B0, Q5T750, Q5T752, Q5T754, Q5T870, Q5T871, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q62266
Diamond homologs: O14633, Q5T5A8, Q5T5B0, Q5TA76, Q5TA77, Q5TA78, Q5TA79, Q5TA81, Q5TA82, Q5TCM9, Q9BYE3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 63 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 33 | 37.5× | 4e-45 |
| Formation of the cornified envelope | 8 | 14.3× | 2e-06 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| hair cycle | 5 | 111.5× | 6e-08 |
| keratinization | 10 | 55.7× | 2e-13 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
146 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:152511513:GCTTT:G | acceptor_gain | 0.9900 |
| 1:152510947:GA:G | donor_gain | 0.9700 |
| 1:152510969:G:T | donor_gain | 0.9600 |
| 1:152511512:A:AG | acceptor_gain | 0.9600 |
| 1:152511513:G:GG | acceptor_gain | 0.9600 |
| 1:152511502:ATT:A | acceptor_loss | 0.9400 |
| 1:152511504:T:A | acceptor_loss | 0.9400 |
| 1:152511512:AGC:A | acceptor_loss | 0.9400 |
| 1:152510969:G:GT | donor_gain | 0.9300 |
| 1:152511503:T:G | acceptor_loss | 0.9300 |
| 1:152510957:G:GT | donor_gain | 0.9000 |
| 1:152510970:A:T | donor_gain | 0.9000 |
| 1:152511513:GCT:G | acceptor_gain | 0.9000 |
| 1:152511580:T:G | donor_gain | 0.9000 |
| 1:152510953:G:GT | donor_gain | 0.8800 |
| 1:152510996:AAG:A | donor_loss | 0.8700 |
| 1:152511000:T:G | donor_loss | 0.8700 |
| 1:152511507:CTTT:C | acceptor_loss | 0.8600 |
| 1:152511499:T:A | acceptor_loss | 0.8500 |
| 1:152511505:GTCTT:G | acceptor_loss | 0.8500 |
| 1:152511506:TCTTT:T | acceptor_loss | 0.8500 |
| 1:152511002:GGTAA:G | donor_loss | 0.8400 |
| 1:152511513:GC:G | acceptor_gain | 0.8400 |
| 1:152511513:GCTT:G | acceptor_gain | 0.8400 |
| 1:152510920:TTG:T | donor_gain | 0.8100 |
| 1:152511510:TCAGC:T | acceptor_gain | 0.8000 |
| 1:152511511:CAGCT:C | acceptor_gain | 0.7900 |
| 1:152510919:GT:G | donor_gain | 0.7800 |
| 1:152511003:G:C | donor_loss | 0.7600 |
| 1:152511611:C:G | donor_gain | 0.7600 |
AlphaMissense
767 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:152511546:G:C | Q4H | 0.740 |
| 1:152511546:G:T | Q4H | 0.740 |
| 1:152511550:A:C | S6R | 0.737 |
| 1:152511552:C:A | S6R | 0.737 |
| 1:152511552:C:G | S6R | 0.737 |
| 1:152511555:G:C | Q7H | 0.696 |
| 1:152511555:G:T | Q7H | 0.696 |
| 1:152511541:T:C | C3R | 0.664 |
| 1:152511562:T:C | C10R | 0.664 |
| 1:152511564:C:G | C10W | 0.663 |
| 1:152511591:A:C | K19N | 0.661 |
| 1:152511591:A:T | K19N | 0.661 |
| 1:152511616:T:C | C28R | 0.633 |
| 1:152511579:A:C | K15N | 0.629 |
| 1:152511579:A:T | K15N | 0.629 |
| 1:152511549:G:C | Q5H | 0.623 |
| 1:152511549:G:T | Q5H | 0.623 |
| 1:152511618:T:G | C28W | 0.621 |
| 1:152511543:C:G | C3W | 0.594 |
| 1:152511580:T:C | C16R | 0.591 |
| 1:152511582:T:G | C16W | 0.586 |
| 1:152511603:G:C | K23N | 0.586 |
| 1:152511603:G:T | K23N | 0.586 |
| 1:152511615:G:C | K27N | 0.586 |
| 1:152511615:G:T | K27N | 0.586 |
| 1:152511558:G:C | Q8H | 0.581 |
| 1:152511558:G:T | Q8H | 0.581 |
| 1:152511592:T:C | C20R | 0.569 |
| 1:152511742:A:C | S70R | 0.565 |
| 1:152511744:C:A | S70R | 0.565 |
dbSNP variants (sampled 300 via entrez): RS1000956174 (1:152512157 A>C,G), RS1001385005 (1:152508889 G>A), RS1001505755 (1:152509261 G>A,C), RS1001623251 (1:152509387 G>A), RS1001696735 (1:152509804 A>G), RS1002334269 (1:152509962 A>T), RS1004125421 (1:152510352 G>A,C), RS1005264269 (1:152510212 T>C), RS1005293645 (1:152510566 T>C,G), RS1007633468 (1:152509065 CA>C), RS1008462569 (1:152512122 T>C), RS1008847890 (1:152511947 T>A,C), RS1008860855 (1:152510686 A>C), RS1009752316 (1:152509631 C>G,T), RS1009878173 (1:152510909 C>T)
Disease associations
OMIM: gene MIM:612619 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000519_10 | Hair morphology | 4.000000e-06 |
| GCST002740_5 | Inflammatory skin disease | 2.000000e-12 |
| GCST003180_3 | Atopic march | 9.000000e-11 |
| GCST007563_33 | Allergic disease (asthma, hay fever or eczema) | 3.000000e-11 |
| GCST007564_24 | Asthma or allergic disease (pleiotropy) | 5.000000e-12 |
| GCST008916_75 | Asthma | 2.000000e-08 |
| GCST008916_82 | Asthma | 5.000000e-27 |
| GCST008916_88 | Asthma | 1.000000e-25 |
| GCST012462_1 | Asthma and eczema | 2.000000e-06 |
| GCST012489_17 | Heel bone mineral density x serum urate levels interaction | 6.000000e-11 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005038 | hair morphology |
| EFO:0007755 | atopic march |
| EFO:0004531 | urate measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): atopic eczema